Tag #Male Contraceptive

Showing 1 to 3 of 3 results

dailymail.co.uk

🌐 85% Global Worthiness

Apr 25, 13:18

Non-Hormonal Male Contraceptive Gel Shows Two-Year Efficacy in Small Trial

Contraline's Adam, a non-hormonal male contraceptive gel injected into the vas deferens, successfully blocked sperm release for two years in a small trial of 25 men, showing promise as a long-term reversible alternative to vasectomy or condoms, although further trials are needed to confirm efficacy ...

Non-Hormonal Male Contraceptive Gel Shows Two-Year Efficacy in Small Trial

Contraline's Adam, a non-hormonal male contraceptive gel injected into the vas deferens, successfully blocked sperm release for two years in a small trial of 25 men, showing promise as a long-term reversible alternative to vasectomy or condoms, although further trials are needed to confirm efficacy ...

Progress

64% Bias Score

ShareSaveArticle

Gender Equality

12345678

Previous 1 of 8 Next

What are the immediate implications of Adam's two-year efficacy in preventing sperm release for male contraception?

A new non-hormonal male contraceptive gel, Adam, effectively blocked sperm release for two years in a small trial of 25 men. The gel, injected into the vas deferens, showed no serious side effects in the two participants completing the trial. This offers a potential long-term, reversible alternative to vasectomies and condoms.

dailymail.co.uk

🌐 85% Global Worthiness

Apr 7, 13:16

Hormone-Free Male Contraceptive Pill Shows Promise in Human Trials

US scientists are testing YCT-529, a hormone-free male birth control pill, which showed 99% efficacy in animal trials and is now in human phase 2 trials in New Zealand, offering a potential game-changer in male contraception.

Hormone-Free Male Contraceptive Pill Shows Promise in Human Trials

US scientists are testing YCT-529, a hormone-free male birth control pill, which showed 99% efficacy in animal trials and is now in human phase 2 trials in New Zealand, offering a potential game-changer in male contraception.

Progress

60% Bias Score

ShareSaveArticle

Gender Equality

12345678

Previous 1 of 8 Next

What is the significance of YCT-529's success in human trials for global reproductive health?

YCT-529, a hormone-free male contraceptive pill, is undergoing human trials after showing 99% pregnancy prevention in mice and monkeys. If successful, it will offer men a new birth control option beyond condoms and vasectomies, significantly impacting family planning.

theguardian.com

🌐 85% Global Worthiness

Apr 24, 16:15

Non-Hormonal Male Contraceptive Shows 24-Month Efficacy in Phase 1 Trial

Contraline's Adam, a non-hormonal male contraceptive hydrogel implant, successfully blocked sperm release for 24 months in a phase 1 trial of 25 men, with no serious side effects reported; further trials are planned to assess reversibility.

Non-Hormonal Male Contraceptive Shows 24-Month Efficacy in Phase 1 Trial

Contraline's Adam, a non-hormonal male contraceptive hydrogel implant, successfully blocked sperm release for 24 months in a phase 1 trial of 25 men, with no serious side effects reported; further trials are planned to assess reversibility.

Progress

52% Bias Score

ShareSaveArticle

Gender Equality

12345678

Previous 1 of 8 Next

How does Adam's design address limitations of previous non-hormonal male contraceptive implants?

The Adam implant's success builds upon previous male contraceptive research, addressing limitations of existing methods. Unlike some implants using non-biodegradable materials, Adam's water-soluble hydrogel is designed to break down after a set time, restoring fertility. This addresses concerns of permanent sterilization and irreversible scarring associated with other approaches.

Showing 1 to 3 of 3 results